FDA Investigates Link Between Asthma Drug Singulair and Mental Health Risks
The Food and Drug Administration (FDA) has announced that new research suggests the asthma drug Singulair, known generically as montelukast, ...
Depression is a mental health disorder characterized by persistent feelings of sadness, hopelessness, and a lack of interest or pleasure. It affects thoughts, emotions, and physical well-being, often requiring therapeutic intervention and support for recovery.
The Food and Drug Administration (FDA) has announced that new research suggests the asthma drug Singulair, known generically as montelukast, ...
A deficiency in Vitamin D3 can significantly impact health, leading to a range of symptoms that signal the need for ...
A recent meta-analysis reveals that young individuals suffering from chronic pain exhibit significantly higher rates of anxiety and depression compared ...
PETALING JAYA, August 29, 2024 — The mental health crisis among Malaysian children has reached alarming proportions, with the rate ...
A recent study published in The BMJ has revealed that high-dose psilocybin may be more effective than traditional antidepressants, such ...
Substance abuse has been a growing concern across the globe, impacting millions of individuals and their families. The relationship between ...
In today's digital age, social media has become an integral part of daily life, connecting people across the globe and ...
Stress is an unavoidable part of life. Whether it stems from work, relationships, financial difficulties, or other challenges, everyone experiences ...
In our fast-paced world, the importance of physical exercise often focuses on its physical benefits—weight management, cardiovascular health, and muscular ...
In a groundbreaking development for cancer care, the National Cancer Institute (NCI) has awarded a $3.1 million grant to support ...
Eli Lilly & Co. has announced that the U.S. Food and Drug Administration (FDA) has approved its drug, Omvoh, for...
Copyright © 2024 dailyhealthways.com